Search

everythinglearnresearchcommunity

for

Search:↓

Human hair has a protective lipid layer that can be damaged by moisture and treatments, affecting hair growth and health.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Hydrogen peroxide and monoethanolamine in hair dye can cause dermatitis and hair loss.

Minoxidil affects cell growth in two ways: low doses increase growth, while high doses slow it down and can be toxic.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Finasteride reduces hair growth and is safe for women with excessive hair.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Scalp hair follicle culture has limits for testing minoxidil's hair growth effects.

Procyanidin B-2 is safe to use on skin as a hair growth product.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Minoxidil helps treat pattern hair loss in both men and women.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Removing external lipids from hair reduces moisture and increases strength, while removing internal lipids decreases water permeability.

Acne is an important sign of androgen excess disorders in women.